Spelling suggestions: "subject:"main -- physiopathologie."" "subject:"gain -- physiopathologie.""
1 |
Abdominal symptoms and anorectal function in outpatients with the irritable bowel syndrome (IBS) /Gudmundur Ragnarsson. January 1900 (has links) (PDF)
Diss. (sammanfattning) Linköping : Univ. / Härtill 5 uppsatser.
|
2 |
Masseter muscle pain and its relation to pain mediators in fibromyalgia and local myalgia /Hedenberg-Magnusson, Britt, January 2001 (has links)
Diss. (sammanfattning) Stockholm : Karolinska institutet, 2001. / Härtill 6 uppsatser.
|
3 |
Cathepsin G: a novel gene for the regulation of pain. / CUHK electronic theses & dissertations collectionJanuary 2011 (has links)
Liu, Xiaodong. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2011. / Includes bibliographical references (leaves 135-155). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese.
|
4 |
Attentional, emotional and psychosocial influences on pain : psychophysics and neuroanatomical correlatesLoggia, Marco L. January 2008 (has links)
This dissertation presents three experiments designed to demonstrate the effects of cognitive, emotional and psychosocial factors on pain perception in humans and to identify potential neuroanatomical substrates of attentional and emotional pain modulation. / The first two chapters provide an introduction, including the statement of the rationale and objectives of this Ph.D. project (Chapter 1) and an overview of the relevant background literature (Chapter 2). / Chapter 3 presents a voxel-based morphometry study on the neural correlates of attentional and emotional pain modulation. In agreement with the observation that manipulations of emotion and attention differentially affect pain perception, the results of this experiment suggest that separate neuroanatomical substrates may underlie these pain modulations: the right lateral orbitofrontal, left medial prefrontal, and bilateral entorhinal cortices appear to be implicated in emotional pain modulation, while the right putamen appears to be involved in attentional pain modulation. / The study described in Chapter 4 shows that the experimental manipulation of mood using emotionally-laden visual stimuli preferentially alters pain unpleasantness, leaving pain intensity unaffected. This study replicates the psychophysical observations presented in the study of Chapter 3 (and in previous reports), which used odors to manipulate emotional state, therefore suggesting the independence of this phenomenon from the mood induction technique employed. / The study in Chapter 5 shows that empathy has an effect on pain perception as well, which cannot be explained by mood effects. Participants for whom a state of high empathy was evoked rated painful stimuli applied to themselves as more intense and unpleasant than did those in a state of low empathy; furthermore, the state empathy ratings correlated with the pain ratings. / By showing that emotional state, attention and empathy can influence pain perception, the work in this thesis provides evidence demonstrating that the pain experience can be significantly molded by top-down factors, and is therefore far from being solely determined by the physical properties of the noxious stimulation. These observations might partially explain why the pain response in certain situations appears disproportionately large, or surprisingly small, in relation to the noxious stimulation, and support the utility of psychological methods in the management of pain symptoms.
|
5 |
Ring A-reduced progesterone metabolites : potential link between pain and depression and measurement of physiological concentrationsOcvirk, Rok. January 2007 (has links)
No description available.
|
6 |
Attentional, emotional and psychosocial influences on pain : psychophysics and neuroanatomical correlatesLoggia, Marco L. January 2008 (has links)
No description available.
|
7 |
Avaliação do tratamento da dor crônica em ombros de hemiplégicos com bloqueio transforaminal de C6: um estudo duplo cego randomizado sham-controlado / Transforaminal epidural steroid injection to treat hemiplegic shoulder pain: a randomized, double-blind, sham-controlled trialAmadera, João Eduardo Daud 05 December 2013 (has links)
Objetivo: A taxa de falha terapêutica para dor crônica em ombros de hemiplégicos (DOH) pós acidente vascular encefálico (AVE) é significante. Diversas abordagens terapêuticas têm sido propostas, porém os resultados dos estudos que as têm investigado demostram resultados controversos. Objetivo: Elaborar um protocolo para avaliar a eficácia da injeção de dexametasona via transforaminal (TF) na DOH. Métodos: Ensaio clínico randomizado, controlado por placebo, com cegamento de pacientes e avaliadores de desfecho. Ambiente clínico: Departamento de Ortopedia e Neurocirurgia de um hospital terciário. Participantes: Pacientes (N = 38) com DOH refratária ao tratamento conservador e escore de dor em repouso superior a quatro centímetros na escala visual analógica de dor (EVA) de 0 a 10 centímetros. Intervenção: TF no nível C5-C6. Comparador: Intervenção sham. Medida de desfecho principal: Variação na EVA três meses após a intervenção. Seguimento: As avaliações foram realizadas imediatamente antes, uma semana após e três meses depois das intervenções. Resultados: TF com dexametasona reduziu significantemente a intensidade da dor quando comparado com o grupo sham (p < 0,001). Adicionalmente, a Medida de Independência Funcional, a algometria do músculo trapézio, a algometria dos dermátomos de C4 e C5 e a algometria dos ligamentos interespinhosos de C6-7 e C7-T1 melhoraram ao término do tratamento no grupo TF (p < 0,05). Não foram relatados efeitos colaterais significantes. Conclusões: TF com dexametasona demonstrou ser eficaz no alívio da dor no ombro em pacientes pós-AVE quando comparado com placebo. Ensaios clínicos maiores são necessários para confirmar esses achados / Objective: Because of the lack of effective treatment today for hemiplegic shoulder pain (HSP) we designed a protocol to evaluate the efficacy of transforaminal epidural dexamethasone injection (TFESI) in relieving it. Design: A randomized, blind, sham-controlled trial with assessments before and after TFESI. Setting: Orthopedics and Neurosurgery department of a tertiary hospital. Participants: Patients (N=38) with HSP refractory to standard treatments and pain score at rest greater than 4cm on a pain visual analog scale (VAS) of 0 to 10cm. Intervention: TFESI at the C5-6 level. Main Outcome Measure: Variation in VAS score 3 months after interventions. Methods: We performed a randomized, sham-controlled, double blind clinical trial in which 38 patients were randomized to receive TFESI (\"TFESI\" group) or sham (\"sham\" group). Assessments were performed immediately before, 1 week after and 3 months after by a blinded rater. Results: At baseline, groups did not differ regarding any of the outcome variables. After 3 months pain intensity was significantly better in the TFESI group as compared to Sham (p < 0.05). For the secondary outcome measures, the functional independency, the algometry of the trapezius muscle and at the C4 and at the C5 levels and the algometry of the ligment at the C6-7 and at the C7-T1 levels also improved after the TFESI treatment (p < 0.05). No side effects were found. Conclusions: TFESI is effective for pain relief and functional independency in patients with HSP. The results of this study suggest that TF has a superior effect compared with Sham intervention. Larger randomized controlled trials should be made to confirm efficacy of TFESI in patients with refractory HSP
|
8 |
Avaliação do tratamento da dor crônica em ombros de hemiplégicos com bloqueio transforaminal de C6: um estudo duplo cego randomizado sham-controlado / Transforaminal epidural steroid injection to treat hemiplegic shoulder pain: a randomized, double-blind, sham-controlled trialJoão Eduardo Daud Amadera 05 December 2013 (has links)
Objetivo: A taxa de falha terapêutica para dor crônica em ombros de hemiplégicos (DOH) pós acidente vascular encefálico (AVE) é significante. Diversas abordagens terapêuticas têm sido propostas, porém os resultados dos estudos que as têm investigado demostram resultados controversos. Objetivo: Elaborar um protocolo para avaliar a eficácia da injeção de dexametasona via transforaminal (TF) na DOH. Métodos: Ensaio clínico randomizado, controlado por placebo, com cegamento de pacientes e avaliadores de desfecho. Ambiente clínico: Departamento de Ortopedia e Neurocirurgia de um hospital terciário. Participantes: Pacientes (N = 38) com DOH refratária ao tratamento conservador e escore de dor em repouso superior a quatro centímetros na escala visual analógica de dor (EVA) de 0 a 10 centímetros. Intervenção: TF no nível C5-C6. Comparador: Intervenção sham. Medida de desfecho principal: Variação na EVA três meses após a intervenção. Seguimento: As avaliações foram realizadas imediatamente antes, uma semana após e três meses depois das intervenções. Resultados: TF com dexametasona reduziu significantemente a intensidade da dor quando comparado com o grupo sham (p < 0,001). Adicionalmente, a Medida de Independência Funcional, a algometria do músculo trapézio, a algometria dos dermátomos de C4 e C5 e a algometria dos ligamentos interespinhosos de C6-7 e C7-T1 melhoraram ao término do tratamento no grupo TF (p < 0,05). Não foram relatados efeitos colaterais significantes. Conclusões: TF com dexametasona demonstrou ser eficaz no alívio da dor no ombro em pacientes pós-AVE quando comparado com placebo. Ensaios clínicos maiores são necessários para confirmar esses achados / Objective: Because of the lack of effective treatment today for hemiplegic shoulder pain (HSP) we designed a protocol to evaluate the efficacy of transforaminal epidural dexamethasone injection (TFESI) in relieving it. Design: A randomized, blind, sham-controlled trial with assessments before and after TFESI. Setting: Orthopedics and Neurosurgery department of a tertiary hospital. Participants: Patients (N=38) with HSP refractory to standard treatments and pain score at rest greater than 4cm on a pain visual analog scale (VAS) of 0 to 10cm. Intervention: TFESI at the C5-6 level. Main Outcome Measure: Variation in VAS score 3 months after interventions. Methods: We performed a randomized, sham-controlled, double blind clinical trial in which 38 patients were randomized to receive TFESI (\"TFESI\" group) or sham (\"sham\" group). Assessments were performed immediately before, 1 week after and 3 months after by a blinded rater. Results: At baseline, groups did not differ regarding any of the outcome variables. After 3 months pain intensity was significantly better in the TFESI group as compared to Sham (p < 0.05). For the secondary outcome measures, the functional independency, the algometry of the trapezius muscle and at the C4 and at the C5 levels and the algometry of the ligment at the C6-7 and at the C7-T1 levels also improved after the TFESI treatment (p < 0.05). No side effects were found. Conclusions: TFESI is effective for pain relief and functional independency in patients with HSP. The results of this study suggest that TF has a superior effect compared with Sham intervention. Larger randomized controlled trials should be made to confirm efficacy of TFESI in patients with refractory HSP
|
Page generated in 0.0539 seconds